Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
71,941,794
-
Number of holders
-
660
-
Total 13F shares, excl. options
-
67,352,622
-
Shares change
-
-1,825,706
-
Total reported value, excl. options
-
$28,445,255,423
-
Value change
-
-$757,416,674
-
Put/Call ratio
-
1.25%
-
Number of buys
-
320
-
Number of sells
-
-289
-
Price
-
$424.54
Significant Holders of WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) as of Q3 2021
736 filings reported holding WST - WEST PHARMACEUTICAL SERVICES INC - Common Stock as of Q3 2021.
WEST PHARMACEUTICAL SERVICES INC - Common Stock (WST) has 660 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,352,622 shares
of 71,941,794 outstanding shares and own 93.62% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (8,530,359 shares), BlackRock Inc. (7,430,013 shares), PRICE T ROWE ASSOCIATES INC /MD/ (5,090,474 shares), STATE STREET CORP (3,401,199 shares), FRANKLIN RESOURCES INC (2,978,310 shares), APG Asset Management N.V. (2,539,868 shares), WCM INVESTMENT MANAGEMENT, LLC (1,442,820 shares), FMR LLC (1,370,872 shares), GEODE CAPITAL MANAGEMENT, LLC (1,341,736 shares), and Invesco Ltd. (1,260,099 shares).
This table shows the top 660 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.